Mitochondrial DNA haplogroups and incidence of lipodystrophy in HIV-infected patients on long-term antiretroviral therapy

Journal of Acquired Immune Deficiency Syndromes

Volumn 59, Issue 2, 2012, Pages 113-120

  De Luca, Andrea ^a,b   Nasi, Milena ^c   Di Giambenedetto, Simona ^a   Cozzi Lepri, Alessandro ^d   Pinti, Marcello ^c   Marzocchetti, Angela ^a   Mussini, Cristina ^e   Fabbiani, Massimiliano ^a   Bracciale, Laura ^a   Cauda, Roberto ^a   Cossarizza, Andrea ^c  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e UNIVERSITY HOSPITAL OF TRIESTE   (Italy)

Author keywords

Genomics; HIV 1; Lipodystrophy; Mitochondria; Toxicity

Indexed keywords

ABACAVIR; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; LAMIVUDINE; MITOCHONDRIAL DNA; NEVIRAPINE; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ADULT; ARTICLE; FEMALE; GENETIC PREDISPOSITION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; INCIDENCE; LIPID STORAGE; LIPOATROPHY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 84857035135     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31823daff3.     Document Type: Article

References (26)

1. Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS. 1998; 12: F51-F58. (Pubitemid 28190689)
2. Haubrich RH, Riddler SA, DiRienzo AG, et al. Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitorsparing regimens for initial HIV treatment. AIDS. 2009; 23: 1109-1118.
3. Noor MA, Seneviratne T, Aweeka FT, et al. Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebocontrolled study. AIDS. 2002; 16: F1-F8. (Pubitemid 34274457)
4. Brown TT, Li X, Cole SR, et al. Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the multicenter AIDS cohort study. AIDS. 2005; 19: 1375-1383. (Pubitemid 41800673)
5. Brinkman K, Smeitink JA, Romijn JA, et al. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet. 1999; 354: 1112-1115. (Pubitemid 29452832)
6. Cossarizza A, Moyle G. Antiretroviral nucleoside and nucleotide analogues and mitochondria. AIDS. 2004; 18: 137-151. (Pubitemid 38253435)
7. Cossarizza A, Mussini C, Viganò A. Mitochondria in the pathogenesis of lipodystrophy induced by anti-HIV antiretroviral drugs: actors or bystanders? Bioessays. 2001; 23: 1070-1080.
8. Ferraresi R, Troiano L, Roat E, et al. Protective effect of acetyl- L-carnitine against oxidative stress induced by antiretroviral drugs. FEBS Lett. 2006; 580: 6612-6616. (Pubitemid 44827022)
9. Torroni A, Huoponen K, Francalacci P, et al. Classification of European mtDNAs from an analysis of three European populations. Genetics. 1996; 144: 1835-1850. (Pubitemid 26427929)
10. Rego-Pérez I, Fernández-Moreno M, Fernández- López C, et al. Mitochondrial DNA haplogroups: role in the prevalence and severity of knee osteoarthritis. Arthritis Rheum. 2008; 58: 2387-2396.
11. Rosa A, Fonseca BV, Krug T, et al. Mitochondrial haplogroup H1 is protective for ischemic stroke in Portuguese patients. BMC Med Genet. 2008; 9: 57.
12. Datta S, Majumder M, Biswas NK, et al. Increased risk of oral cancer in relation to common Indian mitochondrial polymorphisms and autosomal GSTP1 locus. Cancer. 2007; 110: 1991-1999. (Pubitemid 350036858)
13. Li XY, Su M, Huang HH, Li H, et al. mtDNA evidence: genetic background associated with related populations at high risk for esophageal cancer between Chaoshan and Taihang Mountain areas in China. Genomics. 2007; 90: 474-481. (Pubitemid 47404798)
14. Bai RK, Leal SM, Covarrubias D, et al. Mitochondrial genetic background modifies breast cancer risk. Cancer Res. 2007; 67: 4687-4694. (Pubitemid 46910174)
15. Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet. 2005; 39: 359-407. (Pubitemid 43011120)
16. van der Walt JM, Nicodemus KK, et al. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet. 2003; 72: 804-811. (Pubitemid 36403301)
17. Hendrickson SL, Hutcheson HB, Ruiz-Pesini E, et al. Mitochondrial DNA haplogroups influence AIDS progression. AIDS. 2008; 22: 2429-2439.
18. Bonnet E, Genoux A, Bernard J, et al. Impact of genetic polymorphisms on the risk of lipid disorders in patients on anti-HIV therapy. Clin Chem Lab Med. 2007; 45: 815-821. (Pubitemid 47041885)
19. Zanone Poma B, Riva A, Nasi M, et al. Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIVrelated lipodystrophy. AIDS. 2008; 22: 1769-1778.
20. Nasi M, Guaraldi G, Orlando G, et al. Mitochondrial DNA haplogroups and highly active antiretroviral therapy-related lipodystrophy. Clin Infect Dis. 2008; 47: 962-968.
21. Hulgan T, Tebas P, Canter JA, et al. Mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy. J Infect Dis. 2008; 193: 858-866. (Pubitemid 351417009)
22. Hendrickson SL, Kingsley LA, Ruiz-Pesini E, et al. Mitochondrial DNA haplogroups influence lipoatrophy after highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2009; 51: 111-116.
23. Wiesbauer M, Meierhofer D, Mayr JA, et al. Multiplex primer extension analysis for rapid detection of major European mitochondrial haplogroups. Electrophoresis. 2006; 27: 3864-3868. (Pubitemid 44608405)
24. Manwaring N, Jones MM, Wang JJ, et al. Prevalence of mitochondrial DNA haplogroups in an Australian population. Intern Med J. 2006; 36: 530-533. (Pubitemid 43990907)
25. Galli M, Cozzi-Lepri A, Ridolfo AL, et al. Incidence of adipose tissue alterations in first-line antiretroviral therapy: the LipoICoNa study. Arch Intern Med. 2002; 162: 2621-2628. (Pubitemid 35453502)
26. Law M, Puls R, Cheng AK, et al. Evaluation of the HIV lipodystrophy case definition in a placebo-controlled, 144-week study in antiretroviralnaive adults. Antivir Ther. 2007; 11: 179-186.